InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,305.02
(
0.71%
)
US TECH 100
18,342.60
(
1.08%
)
Dow Jones
39,115.86
(
0.13%
)
Brent Oil
82.04
(
0.90%
)
Bitcoin
68,953.98
(
1.52%
)
Post# of 402926
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

sox040713

Send PM Follow Ignore
Followers 56
Posts 5540
Boards Moderated 0
Alias Born 11/04/2011

sox040713

Re: None

Saturday, 05/27/2017 7:15:07 PM

Saturday, May 27, 2017 7:15:07 PM

Post# of 402926
Kepivance, the only approved drug for OM, charges $10K per cycle, but it's hardly effective. There are about 500K patients affected by OM each year. If B-OM charges the same as Kepivance, $10K x 500K = $5B in annual sales. I think B-OM will dominate the market due to its efficacy, delivery method (oral rinse) and lack of competitions.



FUD - Fear, uncertainty and doubt, is generally a strategic attempt to influence perception by disseminating negative and dubious or false information.

Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

Start posting your company's news
Only $200 per official company press release!